UCB Showcases Key Rheumatology Data at ACR Convergence 2021
Go back to UCB Showcases Key Rheumatology Data at ACR Convergence 2021| (NYSE: UCB) | Delayed: 34.27 +0.30 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.97 | 52 Week High | $ | |||
| Open | $34.24 | 52 Week Low | $ | |||
| Day High | $34.40 | P/E | N/A | |||
| Day Low | $33.66 | EPS | $ | |||
| Volume | 1,196,243 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 158.01 +157.99 (789,950.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $46.25 | |||
| Open | $0.02 | 52 Week Low | $32.74 | |||
| Day High | $158.85 | P/E | N/A | |||
| Day Low | $153.53 | EPS | $0.00 | |||
| Volume | 15,089 | |||||
